未登录 分享 收藏
Bendamustine, followed by obinutuzumab and idelalisib in chronic lymphocytic leukemia (CLL2-BCG): Final analysis of a multicenter, open-label phase-II-trial Cramer, Paula; von Tresckow, Julia; Fink, Anna-Maria; Robrecht, Sandra; Giza, Adam; Tausch, Eugen; Mueller, Lothar; Knauf, Wolfgang; Zingerle, Matthias; Al-Sawaf, Othman; Langerbeins, Petra; Fischer, Kirsten; Kreuzer, Karl-Anton; Kneba, Michael; Wendtner, Clemens-Martin; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael 分享 收藏
Patient specific real-time PCR in precision medicine - Validation of IG/TR based MRD assessment in lymphoid leukemia Schilhabel, Anke; Szczepanowski, Monika; van Gastel-Mol, Ellen J.; Schillalies, Janina; Ray, Jill; Kim, Doris; Novakova, Michaela; Dombrink, Isabel; van der Velden, Vincent H. J.; Boettcher, Sebastian; Brueggemann, Monika; Kneba, Michael; van Dongen, Jacques J. M.; Langerak, Anton W.; Ritgen, Matthias 分享 收藏
Obinutuzumab, acalabrutinib, and venetoclax, after an optional debulking with bendamustine in relapsed or refractory chronic lymphocytic leukaemia (CLL2-BAAG) a multicentre, open-label, phase 2 trial Cramer, Paula; Furstenau, Moritz; Robrecht, Sandra; Giza, Adam; Zhang, Can; Fink, Anna-Maria; Fischer, Kirsten; Langerbeins, Petra; Al-Sawaf, Othman; Tausch, Eugen; Schneider, Christof; Schetelig, Johannes; Dreger, Peter; Bottcher, Sebastian; Kreuzer, Karl-Anton; Schilhabel, Anke; Ritgen, Matthias; Bruggemann, Monika; Kneba, Michael; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael 分享 收藏
Bendamustine followed by ofatumumab and ibrutinib in chronic lymphocytic leukemia: primary endpoint analysis of a multicenter, open-label, phase II trial (CLL2-BIO) Cramer, Paula; von Tresckow, Julia; Robrecht, Sandra; Bahlo, Jasmin; Furstenau, Moritz; Langerbeins, Petra; Pflug, Natali; Al-Sawaf, Othman; Heinz, Werner J.; Vehling-Kaiser, Ursula; Durig, Jan; Tausch, Eugen; Hensel, Manfred; Sasse, Stephanie; Fink, Anna-Maria; Fischer, Kirsten; Kreuzer, Karl-Anton; Boettcher, Sebastian; Ritgen, Matthias; Kneba, Michael; Wendtner, Clemens-Martin; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael 分享 收藏
Early treatment with FCR versus watch and wait in patients with stage Binet A high-risk chronic lymphocytic leukemia (CLL): a randomized phase 3 trial Herling, Carmen D.; Cymbalista, Florence; Gross-Ophoff-Mueller, Carolin; Bahlo, Jasmin; Robrecht, Sandra; Langerbeins, Petra; Fink, Anna-Maria; Al-Sawaf, Othman; Busch, Raymonde; Porcher, Raphael; Cazin, Bruno; Dreyfus, Brigitte; Ibach, Stefan; Lepretre, Stephane; Fischer, Kirsten; Kaiser, Florian; Eichhorst, Barbara; Wentner, Clemens-Martin; Hoechstetter, Manuela A.; Doehner, Hartmut; Leblond, Veronique; Kneba, Michael; Letestu, Remi; Boettcher, Sebastian; Stilgenbauer, Stephan; Hallek, Michael; Levy, Vincent 分享 收藏
Long Term Follow-up Data and Health-Related Quality of Life in Frontline Therapy of Fit Patients Treated With FCR Versus BR (CLL10 Trial of the GCLLSG) Kutsch, Nadine; Bahlo, Jasmin; Robrecht, Sandra; Franklin, Jeremy; Zhang, Can; Maurer, Christian; De Silva, Nisha; Lange, Elisabeth; Weide, Rudolf; Kiehl, Michael G.; Soekler, Martin; Schlag, Rudolf; Vehling-Kaiser, Ursula; Koechling, Georg; Ploeger, Christoph; Gregor, Michael; Plesner, Torben; Herling, Marco; Fischer, Kirsten; Doehner, Hartmut; Kneba, Michael; Wendtner, Clemens-Martin; Klapper, Wolfram; Kreuzer, Karl-Anton; Boettcher, Sebastian; Stilgenbauer, Stephan; Fink, Anna Maria; Hallek, Michael; Eichhorst, Barbara 分享 收藏
Influence of obesity and gender on treatment outcomes in patients with chronic lymphocytic leukemia (CLL) undergoing rituximab-based chemoimmunotherapy Fuerstenau, Moritz; Hopfinger, Georg; Robrecht, Sandra; Fink, Anna-Maria; Al-Sawaf, Othman; Langerbeins, Petra; Cramer, Paula; Von Tresckow, Julia; Maurer, Christian; Kutsch, Nadine; Hoechstetter, Manuela; Dreyling, Martin; Lange, Elisabeth; Kneba, Michael; Stilgenbauer, Stephan; Doehner, Hartmut; Hensel, Manfred; Kiehl, Michael G.; Jaeger, Ulrich; Wendtner, Clemens-Martin; Goede, Valentin; Fischer, Kirsten; von Bergwelt-Baildon, Michael; Eichhorst, Barbara; Hallek, Michael; Theurich, Sebastian 分享 收藏
Residual abdominal lymphadenopathy after intensive frontline chemoimmunotherapy is associated with inferior outcome independently of minimal residual disease status in chronic lymphocytic leukemia Fuerstenau, M.; Bahlo, J.; Fink, A. M.; Lange, E.; Dreger, P.; Dreyling, M.; Hess, G.; Ritgen, M.; Kneba, M.; Doehner, H.; Stilgenbauer, S.; Wendtner, C. M.; Goede, V.; Fischer, K.; Boettcher, S.; Hallek, M.; Eichhorst, B. 分享 收藏
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial 氟尿嘧啶联合亚叶酸钙，奥沙利铂和多西他赛与氟尿嘧啶或卡培他滨联合顺铂和表阿霉素围手术期化疗治疗局部晚期，可切除的胃或胃食管交界处腺癌 (FLOT4): 一项随机2/3期试验 Al-Batran, Salah-Eddin; Homann, Nils; Pauligk, Claudia; Goetze, Thorsten O.; Meiler, Johannes; Kasper, Stefan; Kopp, Hans-Georg; Mayer, Frank; Haag, Georg Martin; Luley, Kim; Lindig, Udo; Schmiegel, Wolff; Pohl, Michael; Stoehlmacher, Jan; Folprecht, Gunnar; Probst, Stephan; Prasnikar, Nicole; Fischbach, Wolfgang; Mahlberg, Rolf; Trojan, Joerg; Koenigsmann, Michael; Martens, Uwe M.; Thuss-Patience, Peter; Egger, Matthias; Block, Andreas; Heinemann, Volker; Illerhaus, Gerald; Moehler, Markus; Schenk, Michael; Kullmann, Frank; Behringer, Dirk M.; Heike, Michael; Pink, Daniel; Teschendorf, Christian; Loehr, Carmen; Bernhard, Helga; Schuch, Gunter; Rethwisch, Volker; von Weikersthal, Ludwig Fischer; Hartmann, Joerg T.; Kneba, Michael; Daum, Severin; Schulmann, Karsten; Weniger, Joerg; Belle, Sebastian; Gaiser, Timo; Oduncu, Fuat S.; Guentner, Martina; Hozaeel, Wael; Reichart, Alexander; Jaeger, Elke; Kraus, Thomas; Moenig, Stefan; Bechstein, Wolf O.; Schuler, Martin; Schmalenberg, Harald; Hofheinz, Ralf D. 分享 收藏
Short telomeres are associated with inferior outcome, genomic complexity, and clonal evolution in chronic lymphocytic leukemia Jebaraj, Billy Michael Chelliah; Tausch, Eugen; Landau, Dan A.; Bahlo, Jasmin; Robrecht, Sandra; Taylor-Weiner, Amaro N.; Bloehdorn, Johannes; Scheffold, Annika; Mertens, Daniel; Boettcher, Sebastian; Kneba, Michael; Jaeger, Ulrich; Zenz, Thorsten; Wenger, Michael K.; Fingerle-Rowson, Guenter; Wendtner, Clemens; Fink, Anna-Maria; Wu, Catherine J.; Eichhorst, Barbara; Fischer, Kirsten; Hallek, Michael; Doehner, Hartmut; Stilgenbauer, Stephan 分享 收藏
Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV Michel, Christian; Burchert, Andreas; Hochhaus, Andreas; Saussele, Susanne; Neubauer, Andreas; Lauseker, Michael; Krause, Stefan W.; Kolb, Hans-Jochem; Hossfeld, Dieter Kurt; Nerl, Christoph; Baerlocher, Gabriela M.; Heim, Dominik; Bruemmendorf, Tim H.; Fabarius, Alice; Haferlach, Claudia; Schlegelberger, Brigitte; Balleisen, Leopold; Goebeler, Maria-Elisabeth; Haenel, Mathias; Ho, Anthony; Dengler, Jolanta; Falge, Christiane; Moehle, Robert; Kremers, Stephan; Kneba, Michael; Stegelmann, Frank; Koehne, Claus-Henning; Lindemann, Hans-Walter; Waller, Cornelius F.; Spiekermann, Karsten; Berdel, Wolfgang E.; Mueller, Lothar; Edinger, Matthias; Mayer, Jiri; Beelen, Dietrich W.; Bentz, Martin; Link, Hartmut; Hertenstein, Bernd; Fuchs, Roland; Wernli, Martin; Schlegel, Frank; Schlag, Rudolf; de Wit, Maike; Truemper, Lorenz; Hebart, Holger; Hahn, Markus; Thomalla, Joerg; Scheid, Christof; Schafhausen, Philippe; Verbeek, Walter; Eckart, Michael J.; Gassmann, Winfried; Schenk, Michael; Brossart, Peter; Wuendisch, Thomas; Geer, Thomas; Bildat, Stephan; Schaefer, Erhardt; Hasford, Joerg; Hehlmann, Ruediger; Pfirrmann, Markus 分享 收藏
End-of-Treatment Positron Emission Tomography After Uniform First-Line Therapy of B-Cell Posttransplant Lymphoproliferative Disorder Identifies Patients at Low Risk of Relapse in the Prospective German PTLD Registry Zimmermann, Heiner; Denecke, Timm; Dreyling, Martin H.; Franzius, Christiane; Reinke, Petra; Subklewe, Marion; Amthauer, Holger; Kneba, Michael; Riess, Hanno; Trappe, Ralf U. 分享 收藏
Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV Saussele, Susanne; Hehlmann, Ruediger; Fabarius, Alice; Jeromin, Sabine; Proetel, Ulrike; Rinaldetti, Sebastien; Kohlbrenner, Katharina; Einsele, Hermann; Falge, Christiane; Kanz, Lothar; Neubauer, Andreas; Kneba, Michael; Stegelmann, Frank; Pfreundschuh, Michael; Waller, Cornelius F.; Leibundgut, Elisabeth Oppliger; Heim, Dominik; Krause, Stefan W.; Hofmann, Wolf-Karsten; Hasford, Joerg; Pfirrmann, Markus; Mueller, Martin C.; Hochhaus, Andreas; Lauseker, Michael 分享 收藏
Lenalidomide maintenance after first-line therapy for high-risk chronic lymphocytic leukaemia (CLLM1): final results from a randomised, double-blind, phase 3 study Fink, Anna Maria; Bahlo, Jasmin; Robrecht, Sandra; Al-Sawaf, Othman; Aldaoud, Ali; Hebart, Holger; Jentsch-Ullrich, Kathleen; Doerfel, Steffen; Fischer, Kirsten; Wendtner, Clemens-Martin; Noesslinger, Thomas; Ghia, Paolo; Bosch, Francesc; Kater, Arnon P.; Dohner, Hartmut; Kneba, Michael; Kreuzer, Karl-Anton; Tausch, Eugen; Stilgenbauer, Stephan; Ritgen, Matthias; Boettcher, Sebastian; Eichhorst, Barbara; Hallek, Michael 分享 收藏
Gemcitabine combined with the monoclonal antibody nimotuzumab is an active first-line regimen in KRAS wildtype patients with locally advanced or metastatic pancreatic cancer: a multicenter, randomized phase IIb study 吉西他滨联合单克隆抗体尼妥珠单抗是KRAS野生型局部晚期或转移性胰腺癌患者的一线治疗方案: 一项多中心、随机IIb期研究 Schultheis, B.; Reuter, D.; Ebert, M. P.; Siveke, J.; Kerkhoff, A.; Berdel, W. E.; Hofheinz, R.; Behringer, D. M.; Schmidt, W. E.; Goker, E.; De Dosso, S.; Kneba, M.; Yalcin, S.; Overkamp, F.; Schlegel, F.; Dommach, M.; Rohrberg, R.; Steinmetz, T.; Bulitta, M.; Strumberg, D. 分享 收藏
Impact of gender on outcome after chemoimmunotherapy in patients with chronic lymphocytic leukemia: a meta-analysis by the German CLL study group Al-Sawaf, O.; Robrecht, S.; Bahlo, J.; Fink, A. M.; Cramer, P.; von Tresckow, J.; Maurer, C.; Bergmann, M.; Seiler, T.; Lange, E.; Kneba, M.; Stilgenbauer, S.; Doehner, H.; Kiehl, M. G.; Jaeger, U.; Wendtner, C. M.; Fischer, K.; Goede, V.; Hallek, M.; Eichhorst, B.; Hopfinger, G. 分享 收藏
Frequent evolution of copy number alterations in CLL following first-line treatment with FC(R) is enriched with TP53 alterations: results from the CLL8 trial Edelmann, J.; Tausch, E.; Landau, D. A.; Robrecht, S.; Bahlo, J.; Fischer, K.; Fink, A. M.; Bloehdorn, J.; Holzmann, K.; Boettcher, S.; Werner, L.; Kneba, M.; Gribben, J. G.; Neuberg, D. S.; Wu, C. J.; Hallek, M.; Doehner, H.; Stilgenbauer, S. 分享 收藏
Outcome of advanced chronic lymphocytic leukemia following different first-line and relapse therapies: a meta-analysis of five prospective trials by the German CLL Study Group (GCLLSG) Cramer, Paula; Isfort, Susanne; Bahlo, Jasmin; Stilgenbauer, Stephan; Doehner, Hartmut; Bergmann, Manuela; Stauch, Martina; Kneba, Michael; Lange, Elisabeth; Langerbeins, Petra; Pflug, Natali; Kovacs, Gabor; Goede, Valentin; Fink, Anna-Maria; Elter, Thomas; Fischer, Kirsten; Wendtner, Clemens-Martin; Hallek, Michael; Eichhorst, Barbara 分享 收藏
Enhancing natural killer cell-mediated lysis of lymphoma cells by combining therapeutic antibodies with CD20-specific immunoligands engaging NKG2D or NKp30 Kellner, Christian; Guenther, Andreas; Humpe, Andreas; Repp, Roland; Klausz, Katja; Derer, Stefanie; Valerius, Thomas; Ritgen, Matthias; Brueggemann, Monika; van de Winkel, Jan G. J.; Parren, Paul W. H. I.; Kneba, Michael; Gramatzki, Martin; Peipp, Matthias 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
LANCET.png)
.png){kind=icon}
分享.png){kind=icon}
收藏
OAAI